突触损失及其与帕金森病症状严重程度的关联
Sophie E Holmes1,2, Praveen Honhar3,4, Sule Tinaz2
1Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA.
NPJ Parkinson's disease
|February 24, 2024
概括
帕金森病 (PD) 显示了关键大脑区域的突触密度下降,可以用[11C]UCB-J PET成像测量. 这种突触成像生物标志物与症状严重程度和疾病进展相关,为未来治疗提供了希望.
科学领域:
- 神经科学是一个神经科学.
- 放射化学 放射化学是指辐射化学.
- 医疗成像医学成像
背景情况:
- 帕金森病 (PD) 是一种快速进展的神经退行性疾病,目前没有治愈方法.
- 通过体内成像可视化的突触生物标志物显示了跟踪神经退行症的潜力.
- 目前用于PD的治疗方法不会改变疾病的进展.
研究的目的:
- 为了研究帕金森病患者的突触密度和大脑输液,使用[11C]UCB-J PET.
- 确定[11C]UCB-J PET作为PD中突触损失和疾病进展的生物标志物.
- 为了将突触密度的变化与PD患者的临床症状和疾病持续时间相关联.
主要方法:
- 横截面,高分辨率正子发射断层扫描 (PET) 研究.
- 使用放射性追踪器[11C]UCB-J,这是突触囊糖蛋白2A (SV2A) 和突触密度的标记物.
- 包括30个PD个体和30个年龄/性别匹配的健康对照 (HC).
- 评估了早期PET扫描阶段的相对脑输液.
主要成果:
- 证实了黑质体中的突触密度损失,并将发现扩展到其他早期布拉克阶段PD区域 (大脑干,尾状,嗅觉皮层).
- 在尼格拉尔突触密度损失和PD症状严重程度之间展示了直接的关联.
- 观察到PD患者的突触损失分布更广泛,疾病持续时间更长.
- 与HC相比,在PD患者中发现脑输液减少,与疾病持续时间相关.
- [11C]UCB-J PET同时提供了关于突触密度和脑 perfusion 的信息.
结论:
- [11C]UCB-J PET成像有效地测量了PD中的突触密度损失,包括在黑色物质之外的区域.
- 使用[11C]UCB-J PET 的突触成像可以跟踪PD的进展,并与临床症状相关联.
- 这种技术作为一种有价值的生物标志物,有望在帕金森病中开发疾病修饰干预措施.
相关概念视频
Parkinson's Disease: Overview
546
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
546
Neural Regulation
39.4K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.4K
Parkinson's Disease: Treatment
268
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
268
Alzheimer's Disease: Overview
484
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
484
Long-term Depression
2.5K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
2.5K
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
642
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
642


